对于多变量斜率正常纵向和生存数据的联合模型的变量选择
Jiarui Tang1, An-Min Tang2, Niansheng Tang2
1Department of Biostatistics, University of North Carolina at Chapel Hill, NC, USA.
Statistical methods in medical research
|July 6, 2023
概括
这项研究引入了一种用于纵向和生存数据联合建模的新方法,使得参数估计和变量选择能够同时进行. 它解决了非正常性,并确定了改善临床试验分析的显著共变量.
科学领域:
- 生物统计学 生物统计学
- 临床试验 临床试验
- 纵向数据分析 纵向数据分析
- 生存分析的分析.
背景情况:
- 对于纵向和生存数据的现有联合模型通常假定正常性,限制了它们的适用性.
- 需要一些方法来处理纵向结果的非正常性,同时进行变量选择.
- 同时的参数估计和变量选择对于稳健建模复杂的生物医学数据至关重要.
研究的目的:
- 为多变量斜正常纵向和生存数据开发一种新的联合建模框架.
- 在这个框架内,将同时进行参数估计和变量选择纳入其中.
- 为了识别显著的共变量和轨迹函数,并检测纵向数据的正常偏差.
主要方法:
- 使用处罚分线来估计日志基线危险函数.
- 采用矩形积分法来近似条件生存函数.
- 开发了参数估计的蒙特卡洛预期-最大化算法,以及用于变量选择的一步稀疏估计程序.
主要成果:
- 提出的方法有效地在联合模型中同时进行参数估计和变量选择.
- 它成功地确定了重要的协变量和轨迹函数,提高了模型的解释性.
- 该方法可以检测纵向数据的正常偏差,提供更大的灵活性.
结论:
- 这种新的联合建模方法为分析具有非正常性的复杂纵向和生存数据提供了强大的工具.
- 综合变量选择增强了模型的节性,并确定了关键的预测因素.
- 该方法通过模拟研究和现实世界的临床试验示例来验证.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
488
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
488
Assumptions of Survival Analysis
157
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
157
Comparing the Survival Analysis of Two or More Groups
227
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
227
Introduction To Survival Analysis
289
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
289
Truncation in Survival Analysis
241
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
241
Cancer Survival Analysis
397
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
397


